Is Optimind Pharma Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Optimind Pharma Corp (OMND.CN) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Optimind Pharma Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Optimind Pharma Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Optimind Pharma Corp?

Muslim investors may consider investing in Optimind Pharma Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Optimind Pharma Corp classified as HALAL?

Musaffa determines the Shariah status of Optimind Pharma Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Optimind Pharma Corp updated?

The Shariah compliance status of Optimind Pharma Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Optimind Pharma Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Optimind Pharma Corp?

You can check the latest Shariah compliance status of Optimind Pharma Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

OMND.CN Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: April 09, 2026

Report Source: 2026 3rd Quarter Report

Optimind Pharma Corp. Stock Analysis OMND.CN

Canada N/A Nano Cap Report: Q3, 2026

Optimind Pharma Corp. engages in provides medical cannabis. The company is headquartered in Toronto, Ontario. The firm helps people suffering from post-traumatic stress disorder (PTSD), anxiety, depression and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. The firm also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings. Its treatment programs are designed based on scientific research and specific modalities used in many different therapeutic practices. Each treatment program combines the use of psychedelic medicine with therapeutic processing and integration. The company has two different types of treatments. Monotherapy and assisted therapy, all based on a Ketamine capsule. The effects are felt about 30 minutes after, and within two hours of taking the medicine, cognition is resorted to normal.

Key Statistics of Optimind Pharma Corp (OMND.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.01CAD0.01

Today's Open

CAD0.01

Volume

50.00K

P/E Ratio (TTM)

52 Week Range

CAD0.01CAD0.01

Market Cap

550.00K

Avg. Volume

32.14K

Dividend Yield

Financial Metrics & Statements of Optimind Pharma Corp (OMND.CN)

FAQ's for Optimind Pharma Corp (OMND.CN)

According to Musaffa’s Shariah screening methodology, Optimind Pharma Corp (OMND.CN) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.